Executive Director, Global Clinical Development - Asset Lead (Neuropsychiatry)
Bristol Myers Squibb
Summary
This Exec Director Global Clinical Development serves as the Clinical Asset Lead for one or more assets. This role is accountable for all aspects of clinical strategy and execution for the asset and serves as the single point of clinical accountability on the Global Program Team (GPT). This role provides integrated clinical and scientific leadership, setting and executing clinical development strategies and ensuring high-quality delivery of innovative studies, data packages, and regulatory submissions.
Job description
Position Summary
This Exec Director Global Clinical Development serves as the Clinical Asset Lead for one or more assets. This role is accountable for all aspects of clinical strategy and execution for the asset and serves as the single point of clinical accountability on the Global Program Team (GPT). This role provides integrated clinical and scientific leadership, setting and executing clinical development strategies and ensuring high-quality delivery of innovative studies, data packages, and regulatory submissions.
Asset Clinical Strategy & Leadership
- Owns and drives clinical development strategy across assigned indications for the given asset(s), aligned to overall asset strategy and Target Product Profile(s) (TPP).
- Serves as the clinical point of accountability on the cross-functional Global Program Team (GPT).
- Leads Clinical Strategy Team(s) for given asset(s) or oversees Clinical Indication Leads accountable for this role.
- Provides clinical and disease area expertise to integrated disease area, therapeutic level, and portfolio level strategies.
- Represents Clinical as the internal and external authority for the asset/disease area, including regulatory interactions and Business Development support.
- Engages cross-functionally with internal leaders and partners with external investigators, key opinion leaders, and patient advocacy groups.
- Presents clinical strategy, data, and risk assessments to governance bodies, health authorities, and senior leadership.
Clinical Study Design, Execution & Oversight
- Leads a team of physicians and scientists in the design, execution, analysis, and interpretation of all clinical studies for assigned asset(s).
- On larger programs, this role will directly manage Clinical Indication Leads responsible for many of the below activities including direct management of physicians and scientists assigned to studies in the given indication(s).
- Ensures studies meet regulatory, quality, medical, and access objectives and are aligned with target label indications.
- Ensures high quality, timely delivery of innovative protocols and data packages for CSRs and Regulatory Filings; implements quality assurance plans.
- Accountable for clinical content and data quality for CSRs, trial documents, regulatory submissions, briefing books, and publications.
- Oversees trial progress, proactively identifies and mitigates risks, and provides regular status and risk updates to senior management.
- Champions quality, compliance, and GCP adherence across all clinical activities, partnering with Development Operations and Compliance as needed.
Team Leadership & Talent Development
- Sets priorities and resourcing aligned to program objectives.
- Attracts, develops, and retains top clinical talent through effective leadership, mentoring, and training.
- Fosters a culture of scientific excellence, collaboration, innovation, and accountability.
Qualifications & Experience
- MD required; additional Advanced degree in Life Sciences preferred (PhD, PharmD, MS, RN, or related field); Experience in Neuroscience clinical trials a plus.
- Deep clinical and therapeutic area expertise with advanced knowledge of drug development, competitive landscape, and health authority expectations.
- 10+ years of relevant experience, including leadership in the design and execution of multiple clinical trials.
- Verifiable track record of people leadership or matrix leadership, including developing junior colleagues.
- Demonstrated success in people leadership and/or matrix leadership roles.
Requirements
- MD required
- Additional Advanced degree in Life Sciences preferred (PhD, PharmD, MS, RN, or related field)
- Experience in Neuroscience clinical trials a plus
- Deep clinical and therapeutic area expertise
- Advanced knowledge of drug development, competitive landscape, and health authority expectations
- 10+ years of relevant experience
- Leadership in the design and execution of multiple clinical trials
- Verifiable track record of people leadership or matrix leadership
- Demonstrated success in people leadership and/or matrix leadership roles
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Flexible Time Off
- Paid Company Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Leaves of Absence
- Annual Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.